ClinicalTrials.govpublic full text
Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
hiv infections, lipodystrophy, nevirapine, reverse transcriptase inhibitors, anti-hiv agents, triglycerides, abacavir, efavirenz, lipoproteins, ldl cholesterol, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1047309
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.